Korea-based 3billion launches new genomic newborn screening service 3B-NEO

Singapore, June 2 -- 3billion, a South Korea-based AI-powered genomic diagnostics company, has announced the launch of 3B-NEO, a premium genomic newborn screening (gNBS) service designed to identify g... Read More

Japanese dental startup Toregem raises $5.3 M to treat congenital tooth agenesis

Singapore, June 2 -- Japan-based startup Toregem BioPharma has raised approximately $5.3 million (JPY 850 million) in Pre-Series C financing round of an allocation of J-KISS- type stock acquisition ri... Read More

Biond Biologics and Guangzhou-Israel Biotechnology Fund invest $8 M to advance oncology programmes in China

Singapore, June 2 -- Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cancer and immune-mediated diseases, and the Guangzhou-Israel Biotech... Read More

New radiochemical lab opens in Australia to support next-gen cancer treatment

Singapore, June 1 -- The University of Melbourne and radiopharmaceutical manufacturer Cyclotek have opened the Laboratory for Advanced Radiochemical Science (LARS), a new facility designed to accelera... Read More

Korea's SKIA receives US FDA 510(k) clearance for augmented reality surgical guidance system

Singapore, June 1 -- South Korea-based medtech innovator SKIA has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its augmented reality (AR) surgical guidance... Read More

Innovent Biologics and Pfizer ink $10.5 B deal to develop innovative oncology medicines

Singapore, June 1 -- China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collaboration agreement for the research and development of 12 prom... Read More

Eli Lilly announces three acquisitions worth $3.7 B to build infectious disease portfolio

Singapore, June 1 -- US-based Eli Lilly and Company has announced agreements to acquire three companies, Curevo Inc., LimmaTech Biologics AG, and Vaccine Company, Inc., that expand its research and de... Read More

CellProthera Prepares For Phase 3 Push As Regenerative Cardiology Moves Closer To Clinical Reality

Singapore, June 1 -- Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond experimental research into advanced clinical development. A... Read More

Can Microbubbles Replace Magnetic Beads In Cell Therapy Manufacturing?

Singapore, June 1 -- Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintaining product quality and scalability. Traditional magnetic bea... Read More

Australia leads first-in-human trial of cholesterol-lowering genetic therapy

Singapore, May 29 -- The Victorian Heart Hospital and the Victorian Heart Institute will lead a first-in-human clinical trial of a new investigational genetic therapy that aims to lower cholesterol in... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»